Lung Cancers Recruiting Phase 1 Trials for Nivolumab (DB09035)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02946671Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer PatientsTreatment